Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (Omicron) infection

Bette Liu, Sandrine Stepien, Jiahui Qian, Heather Gidding, Katrina Nicopoulos, Janaki Amin, Allen Cheng, Kristine Macartney
doi: https://doi.org/10.1101/2022.12.22.22283869

Article Information

doi 
https://doi.org/10.1101/2022.12.22.22283869
History 
  • December 26, 2022.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Bette Liu1,2,*,
  2. Sandrine Stepien1,
  3. Jiahui Qian1,2,
  4. Heather Gidding1,3,
  5. Katrina Nicopoulos1,
  6. Janaki Amin4,5,
  7. Allen Cheng6,7 and
  8. Kristine Macartney1,8
  1. 1National Centre for Immunisation Research and Surveillance (NCIRS)
  2. 2School of Population Health, University of New South Wales
  3. 3The University of Sydney Northern Clinical School St Leonards, NSW Australia
  4. 4Population and Public Health Division, NSW Ministry of Health
  5. 5Department of Health Sciences, Macquarie University
  6. 6School of Public Health and Preventative Medicine, Monash University
  7. 7Infection Prevention and Healthcare Epidemiology Unit, Alfred Health
  8. 8Faculty of Medicine and Health, University of Sydney
  1. ↵*Corresponding author; email: bette.liu{at}health.nsw.gov.au
Back to top
Posted December 26, 2022.
Download PDF
Data/Code
Email
Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (Omicron) infection
Bette Liu, Sandrine Stepien, Jiahui Qian, Heather Gidding, Katrina Nicopoulos, Janaki Amin, Allen Cheng, Kristine Macartney
medRxiv 2022.12.22.22283869; doi: https://doi.org/10.1101/2022.12.22.22283869
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area